---
$id: https://graph.org.ai/products/commodity/51161546
$type: Product
source: UNSPSC
code: "51161546"
title: "Midaxifylline"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Midaxifylline

**UNSPSC Code**: 51161546
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a phosphodiesterase inhibitor and bronchodilator with the molecular formula C16H25N5O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A937Z0MS6C, chemically known as 8-(1-aminocyclopentyl)-1,3-dipropylxanthine but generally known as midaxifylline, which bears US NIH Compound Identifier 3047747. European Medicines Agency schedules Midaxifylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03288MIG. The term MIDAXIFYLLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 No. 1, 1999, List 41). Most nations schedule midaxifylline under HS 29395900 and SITC 54145. As of Q4 2014, MIDAXIFYLLINE remains the US FDA Preferred Term for this commodity. Midaxifylline bears US NLM identifiers UMLS ID C1881825 and NCI Concept Code C66147. SMILES: O=C1N(C(=O)N(C2NC([NH]C12)C1(N)CCCC1)CCC)CCC.

